Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP334010.RA4Bgu69Fae52GfDKQ2isp8-_PIYP02nfHDl6ng2ssEIU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP334010.RA4Bgu69Fae52GfDKQ2isp8-_PIYP02nfHDl6ng2ssEIU130_assertion type Assertion NP334010.RA4Bgu69Fae52GfDKQ2isp8-_PIYP02nfHDl6ng2ssEIU130_head.
- NP334010.RA4Bgu69Fae52GfDKQ2isp8-_PIYP02nfHDl6ng2ssEIU130_assertion description "[The neoplastic EC cell is characterized by loss of TGFbeta-1-mediated growth inhibition and, similar to glioblastomas, utilizes the TGFbeta system to induce gene responses associated with growth promotion (c-Myc and the ERK pathway), invasion (E-cadherin), and metastasis (MTA1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP334010.RA4Bgu69Fae52GfDKQ2isp8-_PIYP02nfHDl6ng2ssEIU130_provenance.
- NP334010.RA4Bgu69Fae52GfDKQ2isp8-_PIYP02nfHDl6ng2ssEIU130_assertion evidence source_evidence_literature NP334010.RA4Bgu69Fae52GfDKQ2isp8-_PIYP02nfHDl6ng2ssEIU130_provenance.
- NP334010.RA4Bgu69Fae52GfDKQ2isp8-_PIYP02nfHDl6ng2ssEIU130_assertion SIO_000772 17469181 NP334010.RA4Bgu69Fae52GfDKQ2isp8-_PIYP02nfHDl6ng2ssEIU130_provenance.
- NP334010.RA4Bgu69Fae52GfDKQ2isp8-_PIYP02nfHDl6ng2ssEIU130_assertion wasDerivedFrom befree-20140225 NP334010.RA4Bgu69Fae52GfDKQ2isp8-_PIYP02nfHDl6ng2ssEIU130_provenance.
- NP334010.RA4Bgu69Fae52GfDKQ2isp8-_PIYP02nfHDl6ng2ssEIU130_assertion wasGeneratedBy ECO_0000203 NP334010.RA4Bgu69Fae52GfDKQ2isp8-_PIYP02nfHDl6ng2ssEIU130_provenance.